SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
RS2 Europe
RS2 Europe Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
RS2 Europe Spółka z Ograniczoną Odpowiedzialnością
RS2 Europe Spółka z Ograniczoną Odpowiedzialnością (KRS 0000903444, NIP 9571133851) is a Polish company, headquartered in Zielona Góra, Lubuskie voivodeship. RS2 EUROPE operates in: Other research and experimental development on natural sciences and engineering (PKD 72.19.Z). Industry: Research and development. The company has been listed in the National Court Register since May 27, 2021. RS2 EUROPE's most recently reported net revenue was 3.8 M PLN for 2023.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
72.19.ZOther research and experimental development on natural sciences and engineering
Other activities
Credibility rating
78 / 100
Good credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/5 yrs
Board changes
0
0/5 yrs
PKD changes
0
0/5 yrs
Name changes
0
0/5 yrs
Data from 5 years of registry activity.
Payment reliability score from 2021–2023
Current: B (78/100)
Trend: improving (+3.4 pts/year)
High payment credibility - the company's financial condition is good and the risk of cooperating with it is low.
Standard limit from 2021–2023
Current: 547.3 K PLN
Safe: 355.7 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Founded
May 27, 2021
5 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ZIELONA GÓRA
LUBUSKIE
Primary PKD
72.19.Z
Other research and experimental development on natural sciences and…
Share capital
5.0 K PLN
50 shares total
Shareholders
2
shareholders
Board
2 people
Filed years
3 years
2021–2023 · profitable: 2/3
Registry entries
11
latest: February 11, 2025
Revenue
3.8 M PLN
2023
Net profit
908.5 K PLN
2023
Assets
1.2 M PLN
2023
Equity
909.5 K PLN
2023
Valuation
4.8 M PLN
Medium confidence
Rate business credibility - RS2 Europe.
No ratings
News
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase regarding BCX-CM-J - Europe's first veterinary cell-therapy drug from mesenchymal stem cells for dogs with osteoarthritis. Responses to the final EMA questions are due in May 2026; the CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. Pre-commercial biotech: 2024 closed with a PLN 14.9 m loss on zero revenue; cash of PLN 33.6 m at year-end. Trigon DM maintained a buy rating with a price target of PLN 127.2.
News
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) - a pre-commercial biotech specialising in TPD (Targeted Protein Degradation) - closed Q3 2025 with PLN 36 m of cash and grants securing financing to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I - the first patient dosed at Barcelona Clinic Liver Cancer. CT-03 (MCL-1 degrader) nearing clinical entry. Without a new R&D partnership or equity issuance in 2026, the company will need additional financing.
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
RS2 EUROPE's board has 2 members.
Public-procurement proceedings in which RS2 Europe appears as contractor or contracting authority - total contract value, signing dates, procedures and links to the official notices.
3 most recent proceedings
11 historical registry entries for RS2 Europe
Identifier change
GD.VII NS-REJ.KRS/11499/21/985/REGON
Filing documents submitted (4 documents)
Registered office change, Address change, Website change, Articles of association amended
GD.VII NS-REJ.KRS/5705/24/81
Filing documents submitted (2 documents)
Change in Section 1 (basic data)
GD.VII NS-REJ.KRS/5705/24/81/ADE
Latest reporting year
2023
Available years
3
Filing entries
0
Competing companies or those operating in the same market segment as RS2 Europe (in Zielona Góra, industry: Research and development).
ZIELONA GÓRA· Research and development
Revenue 2024: 101.3 M PLN
WSCHOWA· Research and development
Revenue 2024: 18.0 M PLN
GORZÓW WIELKOPOLSKI· Research and development
Revenue 2024: 9.0 M PLN
ZIELONA GÓRA· Research and development
Revenue 2024: 1.5 M PLN
ZIELONA GÓRA· Research and development
Revenue 2024: 1.4 M PLN
SKÓRZYN· Research and development
Revenue 2023: 857.7 K PLN
